Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
4 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Advances towards genome-based acute myeloid leukemia classification: A
comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus
Classification.
Am J Hematol. 2024 Feb 6. doi: 10.1002/ajh.27249.
PubMed
Abstract available
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Am J Hematol. 2024 Feb 5. doi: 10.1002/ajh.27227.
PubMed
Abstract available
De novo accelerated phase of chronic myeloid leukemia should be recognized even
in the era of tyrosine kinase inhibitors.
Am J Hematol. 2024 Feb 5. doi: 10.1002/ajh.27229.
PubMed
Abstract available
Unstable major molecular response as a trigger for next generation
sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia.
Am J Hematol. 2024 Feb 5. doi: 10.1002/ajh.27232.
PubMed
Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor
outcomes with venetoclax-based treatment: a monocentric real-world study.
Ann Hematol. 2024 Feb 8. doi: 10.1007/s00277-024-05646.
PubMed
Abstract available
Late relapse of chronic myeloid leukemia after allogeneic bone marrow
transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with
insights on the molecular landscape.
Ann Hematol. 2024 Feb 7. doi: 10.1007/s00277-024-05649.
PubMed
Abstract available
Conditional survival to assess prognosis in patients with chronic lymphocytic
leukemia.
Ann Hematol. 2024 Feb 3. doi: 10.1007/s00277-024-05627.
PubMed
Abstract available
Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute
leukemia of ambiguous lineage.
Ann Hematol. 2024 Feb 3. doi: 10.1007/s00277-024-05647.
PubMed
Determining treatment tolerance and fitness for intensive chemotherapy in older
adults with AML: a call to action.
Blood. 2024;143:483-487.
PubMed
Abstract available
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves
specificity and potency against AML.
Blood. 2024;143:507-521.
PubMed
Abstract available
Mature plasmacytoid dendritic cell proliferation in association with
mixed-phenotype acute leukemia, T/myeloid.
Blood. 2024;143:561.
PubMed
Two to tango: engineered T cells against AML.
Blood. 2024;143:476-478.
PubMed
The effect of center experience on allogeneic hematopoietic cell transplantation
outcomes in acute myeloid leukemia.
Bone Marrow Transplant. 2024 Feb 6. doi: 10.1038/s41409-024-02222.
PubMed
Abstract available
Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR
T-cell therapy.
Bone Marrow Transplant. 2023 Dec 16. doi: 10.1038/s41409-023-02176.
PubMed
Abstract available
Long-term follow-up of haploidentical haematopoietic stem cell transplantation in
paediatric patients with high-risk acute myeloid leukaemia: Report from a single
centre.
Br J Haematol. 2024;204:585-594.
PubMed
Abstract available
Repeated COVID-19 vaccination to maximum antibody response yields very low
mortality and hospitalisation rates in patients with CLL and MBL.
Br J Haematol. 2024;204:487-491.
PubMed
Abstract available
Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.
Br J Haematol. 2024;204:576-584.
PubMed
Abstract available
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product
varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the
treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Br J Haematol. 2023 Oct 31. doi: 10.1111/bjh.19170.
PubMed
Abstract available
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile
myelomonocytic leukaemia: Genetic evidence of driver function and implications
for diagnostic workup.
Br J Haematol. 2024;204:595-605.
PubMed
Abstract available
Characterization of a novel IDH2-R159H mutation in acute myeloid leukaemia:
Effects on cell metabolism and differentiation.
Br J Haematol. 2024;204:719-723.
PubMed
Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in
hypo- and normocellular MDS and AML.
Br J Haematol. 2024;204:724-729.
PubMed
Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic
leukaemia.
Br J Haematol. 2024;204:561-565.
PubMed
Abstract available
PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on
survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia
with allogeneic haematopoietic stem cell transplantation.
Br J Haematol. 2024;204:628-637.
PubMed
Abstract available
A treatment strategy to mitigate the adverse effect of pretransplant
mogamulizumab on post-transplant clinical outcome in patients with aggressive
ATL.
Br J Haematol. 2024;204:e25-e27.
PubMed
Advanced systemic mastocytosis-Revised classification, new drugs and how we
treat.
Br J Haematol. 2024;204:402-414.
PubMed
Abstract available
How to improve treatment-free remission eligibility in chronic myeloid leukaemia?
Br J Haematol. 2024;204:434-448.
PubMed
Abstract available
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after
allogeneic stem cell transplantation in patients with Philadelphia-positive acute
lymphoblastic leukemia: A multicenter retrospective study.
Cancer. 2024 Feb 5. doi: 10.1002/cncr.35232.
PubMed
Abstract available
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.
Eur J Haematol. 2024 Feb 4. doi: 10.1111/ejh.14170.
PubMed
Abstract available
IN VIVO ACTIVITY OF THE SECOND-GENERATION PROTEASOME INHIBITOR IXAZOMIB AGAINST
PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA XENOGRAFTS.
Exp Hematol. 2024 Feb 4:104176. doi: 10.1016/j.exphem.2024.104176.
PubMed
Abstract available
Integrated gene co-expression network analysis and experimental validation
revealed potential targets of human urine extract CDA-II in treating chronic
myeloid leukemia.
Genomics. 2024 Feb 5:110806. doi: 10.1016/j.ygeno.2024.110806.
PubMed
Abstract available
Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2
Fusion Gene.
J Pediatr Hematol Oncol. 2024 Feb 1. doi: 10.1097/MPH.0000000000002822.
PubMed
Abstract available
Disparity in treatment patterns among Medicare beneficiaries diagnosed with
chronic lymphocytic leukemia: an analysis of patient and contextual factors.
Leuk Lymphoma. 2024 Feb 7:1-11. doi: 10.1080/10428194.2024.2310150.
PubMed
Abstract available
Stem cell allografting for chronic Myeloid leukemia in the tyrosine kinase era -
forgotten but not gone.
Leuk Lymphoma. 2024 Feb 9:1-10. doi: 10.1080/10428194.2024.2313626.
PubMed
Abstract available
LIN28B promotes differentiation of fully transformed AML cells but is dispensable
for fetal leukemia suppression.
Leukemia. 2024 Feb 6. doi: 10.1038/s41375-024-02167.
PubMed
Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC)
associated phenotype in AML patients undergoing allogeneic stem cell
transplantation in CR.
Leukemia. 2024;38:386-388.
PubMed
Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell
self-renewal and disrupt early lymphopoiesis.
Leukemia. 2024;38:455-459.
PubMed
Prognostic impact of CEBPA mutational subgroups in adult AML.
Leukemia. 2024;38:281-290.
PubMed
Abstract available
How to individualize therapy after failing milestones in chronic myeloid
leukaemia: weighting late response and early death from CML against risk of
alternative therapies.
Leukemia. 2024;38:465-466.
PubMed
Response to Pfirrmann et al.'s comment on How should we interpret conclusions of
TKI-stopping studies.
Leukemia. 2024;38:463-464.
PubMed
Interleukin-15 and -21-activated, donor-derived NK cell infusion after
haploidentical HCT in high-risk AML and MDS-a cohort analysis.
Leukemia. 2024;38:451-454.
PubMed
Development of osteonecrosis and improved survival in B-ALL: results of
Children's Oncology Group Trial AALL0232.
Leukemia. 2024;38:258-265.
PubMed
Abstract available
RAB27B-regulated exosomes mediate LSC maintenance via resistance to senescence
and crosstalk with the microenvironment.
Leukemia. 2024;38:266-280.
PubMed
Abstract available
SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate
leukemogenesis.
Leukemia. 2024;38:408-411.
PubMed
Thank you for your interest in scientific medicine.